 |
Module 5: Ethical Issues in Diagnostic and Therapeutic Genetics Research |
|
|
|
Bibliography
Aguilar LK, Aguilar-Cordova E. Evolution of a gene therapy clinical trial. From bench to bedside and back. J Neurooncol. 2003 Dec;65(3):307-15. Anderson DC, Gomez-Mancilla B, Spear BB, Barnes DM, Cheeseman K, Shaw PM, Friedman J, McCarthy A, Brazell C, Ray SC, McHale D, Hashimoto L, Sandbrink R, Watson ML, Salerno RA, Cohen N, Lister CE; Pharmacogenetics Working Group. Elements of informed consent for pharmacogenetic research; perspective of the pharmacogenetics working group. Pharmacogenomics J. 2002;2(5):284-92. Barnbaum DR. The FDA's proposal for public disclosure of adverse events in gene therapy trials. Politics Life Sciences. 2000 Sep;19(2):261-8. Buchanan A, Califano A, Kahn J, McPherson E, Robertson J, Brody B. Pharmacogenetics: Ethical issues and policy options. Kennedy Inst Ethics J. 2002 Mar;12(1):1-15. Cariou A, Chiche JD, Charpentier J, Dhainaut JF, Mira JP. The era of genomics; Impact on sepsis clinical trial design. Crit Care Med. 2002;30:S341-8. Chicurel ME, Dalma-Weiszhausz DD. Microarrays in pharmacogenomics--advances and future promise. Pharmacogenomics. 2002 Sep;3(5):589-601. Cho MK. Are clinical trials of cell transplantation for Duchenne muscular dystrophy ethical? IRB. 1994 Jan-Apr;16(1-2):12-5. Churchill LR, Collins ML, King NM, Pemberton SG, Wailoo KA. Genetic research as therapy: Implications of "gene therapy" for informed consent. J Law Med Ethics. 1998;26:38-47. Collins FS, Green ED, Guttmacher AE, Guyer MS. A vision for the future of genomics research. Nature. 2003 Apr 24;422(6934):835-47. Cook-Deegan RM, McCormack SJ. Intellectual property. Patents, secrecy, and DNA. Science. 2001 Jul 13;293(5528):217. Dettweiler U, Simon P. Points to consider for ethics committees in human gene therapy trials. Bioethics. 2001 Oct;15(5-6):491-500. Eisenberg RS. Reaching through the genome. Adv Genet. 2003;50:209-30; discussion 507-10. Emilien G, Ponchon M, Caldas C, Isacson O, Maloteaux JM. Impact of genomics on drug discovery and clinical medicine. QJM 2000;93:391-423. Fardeau M. Current protocol of a research phase I clinical trial of full-length dystrophin plasmid DNA in Duchenne/Becker muscular dystrophies. Part III. Ethical considerations. Neuromuscul Disord. 2002 Oct;12 Suppl 1:S52-4. Fortina P, Surrey S, Kricka LJ. Molecular diagnostics: Hurdles for clinical implementation. Trends Mol Med. 2002 Jun;8(6):264-6. Freund CL, Clayton EW. Pharmacogenomics and children: Meeting the ethical challenges. Am J Pharmacogenomics. 2003;3(6):399-404. Freund CL, Wilfond BS. Emerging ethical issues in pharmacogenomics: From research to clinical practice. Am J Pharmacogenomics. 2002;2(4):273-81. Gerhold DL, Jensen RV, Gullans SR. Better therapeutics through microarrays. Nat Genet. 2002 Dec;32 Suppl:547-51. Glass KC, Weijer C, Cournoyer D, Lemmens T, Palmour RM, Shapiro SH, Freedman B. Structuring the review of human genetics protocols, part III: Gene therapy studies. IRB. 1999 Mar-Apr;21(2):1-9. Guzey C, Spigset O. Genotyping as a tool to predict adverse drug reactions. Curr Top Med Chem. 2004;4(13):1411-21. Haas DW, Wilkinson GR, Kuritzkes DR, Richman DD, Nicotera J, Mahon LF, Sutcliffe C, Siminski S, Andersen J, Coughlin K, Clayton EW, Haines J, Marshak A, Saag M, Lawrence J, Gustavson J, Anne Bennett J, Christensen R, Matula MA, Wood AJ; Adult AIDS Clinical Trials Group. A multi-investigator/institutional DNA bank for AIDS-related human genetic studies: AACTG Protocol A5128. HIV Clin Trials. 2003 Sep-Oct;4(5):287-300. The International HapMap Consortium. The International HapMap Project. Nature. 2003;426(6968):789-96. Henderson GE, King NM. Studying benefit in gene transfer. IRB. 2001 Mar-Apr;23(2):13-5. High KA. The risks of germline gene transfer. Hastings Cent Rep. 2003 Mar-Apr;33(2):3. Issa AM. Ethical perspectives on pharmacogenomic profiling in the drug development process. Nat Rev Drug Discov. 2002 Apr;1(4):300-8. Jannetto PJ, Laleli-Sahin E, Wong SH. Pharmacogenomic genotyping methodologies. Clin Chem Lab Med. 2004;42(11):1256-64. Kimmelman J. Protection at the cutting edge: The case for central review of human gene transfer research. CMAJ. 2003 Oct 14;169(8):781-2. King NMP, Henderson GE, Churchill LR, Davis AM, Hull SC, Nelson DK, Parham-Vetter PC, Rothschild BB, Easter MM, Wilfond BS. Consent forms and the therapeutic misconception: The example of gene transfer research. IRB. 2005;27:1-8. Kohn EC, Lu Y, Wang H, Yu Q, Yu S, Hall H, Smith DL, Meric-Bernstam F, Hortobagyi GN, Mills GB. Molecular therapeutics: Promise and challenges. Semin Oncol. 2004 Feb;31(1 Suppl 3):39-53. Lee SS. Race, distributive justice and the promise of pharmacogenomics: Ethical considerations. Am J Pharmacogenomics. 2003;3(6):385-92. Lerman C, Shields PG, Wileyto EP, Audrain J, Pinto A, Hawk L, Krishnan S, Niaura R, Epstein L. Pharmacogenetic investigation of smoking cessation treatment. Pharmacogenetics. 2002 Nov;12(8):627-34. National Institutes of Health, "NIH Guidelines for Research Involving Recombinant DNA Molecules," April 2002, Appendix M. Nelson D, Weiss R. Penn researchers sued in gene therapy death: Teen's parents also name ethicist as defendant. Washington Post. 2000 Sep 19;A3. NIH Recombinant DNA Advisory Committee. "Human Gene Transfer Protocols." February 2003, http://www4.od.nih.gov/oba/rac/PROTOCOL.pdf. Norbert PW, Roses AD. Pharmacogenetics and pharmacogenomics: Recent developments, their clinical relevance and some ethical, social, and legal implications. J Mol Med. 2003 Mar;81(3):135-40. The President's Council on Bioethics. Reproduction and responsibility: The regulation of new biotechnologies. Author: Washington, DC March 2004. http://www.bioethics.gov/reports. Rabino I. Gene therapy: Ethical issues. Theor Med Bioeth. 2003;24(1):31-58. Roses AD. Pharmacogenetics and drug development: The path to safer and more effective drugs. Nat Rev Genet. 2004 Sep;5(9):645-56. Rothstein MA. The role of IRBs in research involving biobanks. J Law, Med Ethics. 2002;30:105-8. Rothstein MA. Pharmacogenomics: Social, ethical and clinical dimensions. New Jersey: John Wiley & Sons: 2003. Schubert L. Ethical implications of pharmacogenetics--do slippery slope arguments matter? Bioethics. 2004 Aug;18(4):361-78. Shah R, Darne B, Atar D, Abadie E, Adams KF, Zannad F; 5th Cardiovascular Clinical Trialists Workshop. Pharmacogenomics in cardiovascular clinical trials. Fundam Clin Pharmacol. 2004 Dec;18(6):705-8. Sicard D. Ethical questions raised by in utero therapeutics with stem cells and gene therapy. Fetal Diagn Ther. 2004 Mar-Apr;19(2):124-6. Silva FG. Ethics of the new biology and genetic medicine (molecular ethics): Brief (re)view from the USA. Pathol Int. 2002 Sep;52(9):555-62. Smart A, Martin P, Parker M. Tailored medicine: Whom will it fit? The ethics of patient and disease stratification. Bioethics. 2004 Aug;18(4):322-42. Smith L, Byers JF. Gene therapy in the post-Gelsinger era. JONAS Healthc Law Ethics Regul. 2002 Dec;4(4):104-10. Spink J, Geddes D. Gene therapy progress and prospects: Bringing gene therapy into medical practice: The evolution of international ethics and the regulatory environment. Gene Ther. 2004 Nov;11(22):1611-6. van Ommen GJ. The Human Genome Project and the future of diagnostics, treatment and prevention. J Inherit Metab Dis. 2002 May;25(3):183-8. Vaszar LT, Cho MK, Raffin TA Privacy issues in personalized medicine. Pharmacogenomics. 2003 Mar;4(2):107-12. Vergopoulos A, Knoblauch H, Schuster H. DNA testing for familial hypercholesterolemia: Improving disease recognition and patient care. Am J Pharmacogenomics. 2002;2(4):253-62. Weijer C, Miller PB. Protecting communities in pharmacogenetic and pharmacogenomic research. Pharmacogenomics J. 2004;4(1):9-16. Weinshilboum R, Wang L. Pharmacogenomics: Bench to bedside. Nat Rev Drug Discov. 2004 Sep;3(9):739-48. Yi Y, Hahm SH, Lee KH. Retroviral gene therapy: Safety issues and possible solutions. Curr Gene Ther. 2005 Jan;5(1):25-35.
The materials on this site and in each module are copyrighted by Duke University and Johns Hopkins University and may not be copied, transmitted, or published without explicit written permission. © 2005 Duke Universtiy Medical Center and Johns Hopkins University. Site Design by MediSpin, Inc. Site hosting by Duke Educational Media Services |